MARKET

CDNA

CDNA

Caredx
NASDAQ

Real-time Quotes | Nasdaq Last Sale

25.86
+0.71
+2.82%
After Hours: 25.51 -0.35 -1.35% 17:41 05/20 EDT
OPEN
25.85
PREV CLOSE
25.15
HIGH
26.26
LOW
24.25
VOLUME
487.31K
TURNOVER
0
52 WEEK HIGH
96.88
52 WEEK LOW
21.25
MARKET CAP
1.38B
P/E (TTM)
-27.5429
1D
5D
1M
3M
1Y
5Y
CareDx Sponsored ISHLT Innovation Challenge Award Tackles Chronic Lung Allograft Dysfunction
Donor-Derived Cell-Free DNA will be Used to Evaluate Treatment to Improve Lung Transplant OutcomesSOUTH SAN FRANCISCO, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and...
GlobeNewswire · 4d ago
In CareDx-Initiated IP Litigation Against Natera, Natera Now Drops 1 of 2 Patents Originally Asserted Against CareDx
Natera Recycles Old IP for New Lawsuits SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-valu...
GlobeNewswire · 5d ago
Cathie Wood’s 2022 Portfolio: 10 Small-Cap Stock Picks
In this article, we discuss the 10 small-cap stock picks of Cathie Wood’s 2022 portfolio. If you want to skip our detailed analysis of Wood’s hedge fund performance, stock selection and history, go directly to Cathie Wood’s 2022 Portfolio: 5 Small-Cap Stoc...
Insider Monkey · 6d ago
CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference
Posters and Symposium Feature Latest Advances in AlloSeq Portfolio Including HLA Typing and Hematopoietic Stem Cell and Organ Transplant MonitoringSOUTH SAN FRANCISCO, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Co...
GlobeNewswire · 05/11 11:00
92 Biggest Movers From Friday
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the commercialization of space technologies and services.
Benzinga · 05/09 10:27
55 Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
Benzinga · 05/06 16:00
BRIEF-CareDx Reports First Quarter 2022 Results
reuters.com · 05/05 22:22
CareDx: Q1 Earnings Insights
CareDx (NASDAQ:CDNA) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings CareDx missed estimated earnings by 160.0%, reporting an EPS of $-0.13 versus an estimate of $-0...
Benzinga · 05/05 22:07
More
No Data
Learn about the latest financial forecast of CDNA. Analyze the recent business situations of Caredx through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

57.14%Strong Buy
28.57%Buy
14.29%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average CDNA stock price target is 60.29 with a high estimate of 110.00 and a low estimate of 45.00.
High110.00
Average60.29
Low45.00
Current 25.86
EPS
Actual
Estimate
-0.27-0.17-0.070.04
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 305
Institutional Holdings: 70.29M
% Owned: 132.07%
Shares Outstanding: 53.22M
TypeInstitutionsShares
Increased
79
5.58M
New
29
353.39K
Decreased
63
2.62M
Sold Out
37
886.44K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.64%
Pharmaceuticals & Medical Research
+1.63%
Key Executives
Non-Executive Chairman/Independent Director
Michael Goldberg
President/Chief Executive Officer/Director
Reginald Seeto
Chief Financial Officer
Ankur Dhingra
Chief Marketing Officer
Sasha King
Vice President/Controller
Marcel Konrad
Other
Alexander Johnson
Director
Peter Maag
Director
Arthur Torres
Director
Hannah Valantine
Independent Director
George Bickerstaff
Independent Director
Frederick Cohen
Independent Director
Grace Colon
Independent Director
Christine Cournoyer
Independent Director
William Hagstrom
Independent Director
Ralph Snyderman
No Data
No Data
About CDNA
CareDx, Inc. is a precision medicine company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, which is a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap Heart, which is a gene expression solution for heart transplant patients, and AlloSure Heart, a dd-cf-DNA solution for heart transplant patients. Its suite of AlloSeq products include: AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, TruSight HLA, Olerup SSP and QTYPE. It also provides transplant patient tracking software, Ottr software, as well as of transplant quality tracking and waitlist management solutions.

Webull offers kinds of CareDx Inc stock information, including NASDAQ:CDNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDNA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CDNA stock methods without spending real money on the virtual paper trading platform.